BRIEF published on 02/12/2026 at 18:05, 9 months 5 days ago THX Pharma Announces Webinar on Strategic Agreement with Biocodex Webinar Batten-1 Strategic Agreement THX Pharma Biocodex
PRESS RELEASE published on 02/12/2026 at 18:00, 9 months 5 days ago THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex THX Pharma to host webinar discussing strategic agreement with Biocodex, including licensing terms and development outlook. Webcast on February 17, 6:00 p.m. CET. More info at theranexus.com Webinar Strategic Agreement Neurological Diseases THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 9 months 7 days ago Strategic Licensing Agreement for Rare Disease Treatments Rare Diseases Strategic Agreement Licensing Deal THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 9 months 7 days ago Strategic agreement between THX Pharma and Biocodex for three rare diseases Rare Diseases License Agreement THX Pharma Biocodex Batten-1 And TX01
PRESS RELEASE published on 02/10/2026 at 18:00, 9 months 7 days ago THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases Biocodex acquires licenses from THX Pharma to develop Batten-1 globally and TX01 in US and Canada. Deal worth up to €173M includes milestone payments and double-digit royalties Batten-1 Licenses TX01 THX Pharma Biocodex
BRIEF published on 01/27/2026 at 18:05, 9 months 21 days ago Theranexus Liquidity Contract Half-Year Review Liquidity Contract PORTZAMPARC Financial Report Theranexus THX Pharma Actions
BRIEF published on 01/20/2026 at 18:05, 9 months 28 days ago THX Pharma Reveals 2026 Financial Schedule Financial Calendar Neurological Diseases Market Communication 2026 Announcements THX Pharma
BRIEF published on 01/20/2026 at 18:05, 9 months 28 days ago THX Pharma unveils its 2026 financial calendar Euronext Paris Financial Agenda Biopharmaceutical 2026 THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 9 months 28 days ago THX Pharma Announces its 2026 Financial Calendar THX Pharma (Theranexus) announces financial communication agenda for 2026, focusing on rare neurological diseases treatments. Company listed on Euronext Growth Paris Euronext Growth Paris Financial Communication Theranexus Neurological Diseases THX Pharma
BRIEF published on 01/08/2026 at 18:05, 10 months 9 days ago THX Pharma Releases Shareholder Letter Drug Development Biopharmaceutical Shareholder Communication Neurological Diseases THX Pharma
Published on 11/17/2026 at 15:00, 3 hours 59 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/17/2026 at 14:45, 4 hours 14 minutes ago NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox (Monkeypox)
Published on 11/17/2026 at 14:00, 4 hours 59 minutes ago FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at Osaka Major
Published on 11/17/2026 at 14:00, 4 hours 59 minutes ago Tectonic Metals Completes Record Drill Program at Flat, Advances Five Pillars of Growth Toward Major 2027 Milestones
Published on 11/17/2026 at 18:45, 14 minutes ago HCLTech and Cohere partner to build and deliver sovereign AI
Published on 11/17/2026 at 17:54, 1 hour 4 minutes ago SKAN takes note of the Federal Criminal Court’s first-instance judgments
Published on 11/17/2026 at 18:00, 59 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 17:45, 1 hour 14 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 11 hours 18 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.
Published on 11/17/2026 at 07:30, 11 hours 29 minutes ago PR_Carrefour reaffirms its confidence in the hypermarket model, a pillar of its performance
Published on 11/17/2026 at 06:55, 12 hours 4 minutes ago Recticel Group recognised by TIME among the World's Best Companies for Sustainable Growth 2027